Return to content in this issue

 

Un-Sustained Response to Benralizumab in Eosinophilic Asthma with Previous 3 Year Mepolizumab Administration

Kurosawa M1, Shimizu Y2, Sutoh Y3, Sutoh E1, 3

1Department of Allergy and Respiratory Medicine, Sutoh Hospital, Annaka, Gunma, Japan
2Division of Respiratory Medicine, Kaminakai Family Clinic, Takasaki, Gunma, Japan
3Department of Surgery, Sutoh Hospital, Annaka, Gunma, Japan

J Investig Allergol Clin Immunol 2021; Vol. 31(4)
doi: 10.18176/jiaci.0652

Key words: Anti interleukin 5 therapy, Asthma Control Test, Blood eosinophil count, Eosinophilic asthma, Forced expiratory volume in 1 second